Cargando…

Anti-nociceptive interactions between opioids and a cannabinoid receptor 2 agonist in inflammatory pain

The cannabinoid 1 receptor and cannabinoid 2 receptor can both be targeted in the treatment of pain; yet, they have some important differences. Cannabinoid 1 receptor is expressed at high levels in the central nervous system, whereas cannabinoid 2 receptor is found predominantly, although not exclus...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yuill, Matthew B, Hale, David E, Guindon, Josée, Morgan, Daniel J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2017
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5593227/ https://www.ncbi.nlm.nih.gov/pubmed/28879802 http://dx.doi.org/10.1177/1744806917728227

Ejemplares similares

Anti-nociception mediated by a κ opioid receptor agonist is blocked by a δ receptor agonist
por: Taylor, A M W, et al.
Publicado: (2015)

PM287. Mixtures of opioid receptor agonists and cannabinoid receptor agonists: enhanced antinociception without abuse liability
por: France, Charles P, et al.
Publicado: (2016)

Interaction of Synthetic Cannabinoid Receptor Agonists with Cannabinoid Receptor I: Insights into Activation Molecular Mechanism
por: Gavryushov, Sergei, et al.
Publicado: (2023)

Bifunctional peptide-based opioid agonist/nociceptin antagonist ligand for dual treatment of nociceptive and neuropathic pain
por: Lagard, Camille, et al.
Publicado: (2016)

Participation of cannabinoid receptors in peripheral nociception induced by some NSAIDs
por: Silva, L.C.R., et al.
Publicado: (2012)

Anti-inflammatory and antinociceptive effects of the selective cannabinoid CB(2) receptor agonist ABK5
por: Tang, Yaliang, et al.
Publicado: (2020)

Characterization of Subtype Selective Cannabinoid CB(2) Receptor Agonists as Potential Anti-Inflammatory Agents
por: Tang, Yaliang, et al.
Publicado: (2021)

A2 ACUTE COLITIS CAUSES CHANGES TO THE EFFICACY OF CANNABINOID-1 AND MU-OPIOID RECEPTOR AGONISTS ON INHIBITING ABDOMINAL PAIN
por: Tsang, Q K, et al.
Publicado: (2023)

Exploring determinants of agonist efficacy at the CB1 cannabinoid receptor: Analogues of the synthetic cannabinoid receptor agonist EG‐018
por: Finlay, David B., et al.
Publicado: (2022)

Isobolographic analysis of the opioid-opioid interactions in a tonic and a phasic mouse model of induced nociceptive pain
por: Miranda, Hugo F, et al.
Publicado: (2014)

Cannabinoids and Opioids in the Treatment of Inflammatory Bowel Diseases
por: Kienzl, Melanie, et al.
Publicado: (2020)

2-Arylpropionic Acid Pyrazolamides as Cannabinoid CB2 Receptor Inverse Agonists Endowed with Anti-Inflammatory Properties
por: de Oliveira, Daniela R., et al.
Publicado: (2022)

Evaluating signaling bias for synthetic cannabinoid receptor agonists at the cannabinoid CB(2) receptor
por: Patel, Monica, et al.
Publicado: (2023)

Fluoroscopic Characterization of Colonic Dysmotility Associated to Opioid and Cannabinoid Agonists in Conscious Rats
por: Díaz-Ruano, Susana, et al.
Publicado: (2019)

Dimerization with Cannabinoid Receptors Allosterically Modulates Delta Opioid Receptor Activity during Neuropathic Pain
por: Bushlin, Ittai, et al.
Publicado: (2012)

Modulation of Morphine Analgesia, Antinociceptive Tolerance, and Mu-Opioid Receptor Binding by the Cannabinoid CB2 Receptor Agonist O-1966
por: Reichenbach, Zachary W., et al.
Publicado: (2022)

Anti-Inflammatory and Anti-Nociceptive Effects of Cocoa: A Review on Future Perspectives in Treatment of Pain
por: De Feo, Martina, et al.
Publicado: (2020)

Anti-Inflammatory Activity of a CB2 Selective Cannabinoid Receptor Agonist: Signaling and Cytokines Release in Blood Mononuclear Cells
por: Capozzi, Antonella, et al.
Publicado: (2021)

Better agonist for the opioid receptors
por: Badshah, Syed Lal, et al.
Publicado: (2018)

Interacting Cannabinoid and Opioid Receptors in the Nucleus Accumbens Core Control Adolescent Social Play
por: Manduca, Antonia, et al.
Publicado: (2016)

NSAIDs, Opioids, Cannabinoids and the Control of Pain by the Central Nervous System
por: Vanegas, Horacio, et al.
Publicado: (2010)

Cannabinoid Receptor 1 Agonist ACEA and Cannabinoid Receptor 2 Agonist GW833972A Attenuates Cell-Mediated Immunity by Different Biological Mechanisms
por: Takheaw, Nuchjira, et al.
Publicado: (2023)

Mechanisms of microbial–neuronal interactions in pain and nociception
por: Lagomarsino, Valentina N., et al.
Publicado: (2020)

Anti-Nociceptive and Anti-Inflammatory Activity of Hygrophila schulli Leaves
por: Tekulu, Gebretsadkan Hintsa, et al.
Publicado: (2020)

Orexin Receptor Multimerization versus Functional Interactions: Neuropharmacological Implications for Opioid and Cannabinoid Signalling and Pharmacogenetics
por: Thompson, Miles D., et al.
Publicado: (2017)

Harnessing the Anti-Nociceptive Potential of NK2 and NK3 Ligands in the Design of New Multifunctional μ/δ-Opioid Agonist–Neurokinin Antagonist Peptidomimetics
por: Gadais, Charlène, et al.
Publicado: (2021)

Assessment of select synthetic cannabinoid receptor agonist bias and selectivity between the type 1 and type 2 cannabinoid receptor
por: Zagzoog, Ayat, et al.
Publicado: (2021)

Exploring Binding Properties of Agonists Interacting with a δ-Opioid Receptor
por: Collu, Francesca, et al.
Publicado: (2012)

Detection of Cannabinoid Receptor Expression by Endometriotic Lesions in Women with Endometriosis as an Alternative to Opioid-Based Pain Medication
por: Allam, Sarah, et al.
Publicado: (2022)

Anti-nociceptive, anti-inflammatory and possible mechanism of anti-nociceptive action of methanol leaf extract of Nymphaea lotus Linn (Nymphaeceae)
por: Rege, Musa G., et al.
Publicado: (2020)

Effects of mu- and kappa-2 opioid receptor agonists on pain and rearing behaviors
por: Neubert, John K, et al.
Publicado: (2007)

The Expanding Role of the COX Inhibitor/Opioid Receptor Agonist Combination in the Management of Pain
por: Varrassi, Giustino, et al.
Publicado: (2020)

Role of mu-opioid receptor in nociceptive modulation in anterior cingulate cortex of rats
por: Wang, Linlin, et al.
Publicado: (2020)

Novel N-normetazocine Derivatives with Opioid Agonist/Sigma-1 Receptor Antagonist Profile as Potential Analgesics in Inflammatory Pain
por: Turnaturi, Rita, et al.
Publicado: (2022)

Anti-nociceptive effects of dual neuropeptide antagonist therapy in mouse model of neuropathic and inflammatory pain
por: Kim, Min Su, et al.
Publicado: (2022)

Purinergic ATP triggers moxibustion-induced local anti-nociceptive effect on inflammatory pain model
por: Yin, Hai-Yan, et al.
Publicado: (2021)

Tolerance to the antinociceptive effects of chronic morphine requires c-Jun N-terminal kinase
por: Marcus, David J., et al.
Publicado: (2015)

Cannabinoids suppress inflammatory and neuropathic pain by targeting α3 glycine receptors
por: Xiong, Wei, et al.
Publicado: (2012)

Celastrol Attenuates Inflammatory and Neuropathic Pain Mediated by Cannabinoid Receptor Type 2
por: Yang, Longhe, et al.
Publicado: (2014)

Antiallodynic Effects of Cannabinoid Receptor 2 (CB(2)R) Agonists on Retrovirus Infection-Induced Neuropathic Pain
por: Sheng, Wen S., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_3ohn2n655ejk1rc56pi4s8k3ug